Search results

Order by most recent / most popular / relevance

Results: 1-9 of 9

Updates on China trademark law

Kangxin Partners PC
-
China
-
March 13 2013

Notice on Relevant Proceeding of Newly Added Items for Pharmaceutical Retail or Wholesale Services in Class Thirty Five. The State Administration for

China allows (limited) registrations for retail and distribution services

Wilkinson & Grist
-
China
-
March 6 2013

As of 1st January 2013, China is allowing the registration of trademarks in connection with the retail and distribution of several medicine-related

China Trademark Office accepts retail and wholesale services for pharmaceuticals

Tsai Lee & Chen
-
China
-
February 1 2013

In line with the 10th edition of the Nice Classification of Goods and Services, the China Trademark Office (CTMO) started accepting (on January 1

China allows trademark applications in respect of certain retail or wholesale services in pharmaceutical area

Peksung Intellectual Property Ltd
-
China
-
January 18 2013

According to WIPO, a new version of the tenth edition of the International Classification of Goods and Services for the Purposes of the Registration

CTMO released notice to open trademark registration in retail and wholesale service in China

King & Wood Mallesons
-
China
-
December 21 2012

On December 14, 2012, the China Trademark Office issued a Notice on Adding Trademark Specifications on Retail and Distribution Service Trademark. In this

Drug firm wins herbal tea trademark litigation, trade dress dispute ongoing (Hengyuan Zhiye 2012-07-17) --- July 17, 2012

Reed Smith LLP
-
China
-
August 8 2012

On July 16, the Beijing First Intermediate Court ruled that Guangzhou Pharmaceutical Company Limited owns the “Wong Lo Kat” herbal tea trademark name, ending a lengthy dispute with Hong Kong’s JDB Group

Taking a dual approach to pharmaceuticals

Kangxin Partners PC
-
China
-
September 1 2011

As in most other jurisdictions, in China pharmaceutical companies must navigate a dual system for registration and approval of their trademarks and the commercial names of their products

China SFDA imposes new regulatory requirements on cross-border pharmaceutical contract manufacturing activities

Sidley Austin LLP
-
China
-
August 15 2011

On July 22, 2011, the China State Food and Drug Administration (“SFDA”) published a notice on strengthening its supervision over domestic contract manufacturing activities for foreign pharmaceutical manufacturers (the “Notice”), with an aim to prevent export counterfeiting

Pharmaceutical Trademarks 20102011 A Global Guide: China

CCPIT Patent & Trademark Law Office
-
China
-
September 22 2010

A drug can have three names in China: the generic name, the trade name and the trademark